NCT02399410View on ClinicalTrials.gov

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 4, 2015

Primary Completion Date

November 9, 2023

Study Completion Date

November 9, 2023

Conditions
Colorectal Neoplasms
Interventions
DRUG

perioperative chemotherapy plus bevacizumab

preoperative and postoperative combination chemotherapy with bevacizumab

PROCEDURE

cytoreductive surgery

complete or nearly complete removal of synchronous or metachronous peritoneal carcinomatosis from CRC.

DRUG

Intraperitoneal Oxaliplatin

Pump-driven intraperitoneal administration of oxaliplatin

Trial Locations (1)

9000

Ghent University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER

NCT02399410 - Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis | Biotech Hunter | Biotech Hunter